Clinical trials
Phase 2 Lung Diseases, Interstitial trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2012 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2020 | 2 |
| 2022 | 2 |
| 2024 | 3 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 5 |
| Terminated | 5 |
| Completed | 3 |
| Recruiting | 3 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Celgene | 2 |
| Novartis Pharmaceuticals | 2 |
| Avalyn Pharma Inc. | 1 |
| Bristol-Myers Squibb | 1 |
| Cambridge University Hospitals NHS Foundation Trust | 1 |
| Contineum Therapeutics | 1 |
| EMD Serono Research & Development Institute, Inc. | 1 |
| Hoffmann-La Roche | 1 |
| Insmed Incorporated | 1 |
| Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lung Diseases, Interstitial | 17 |
| Pulmonary Fibrosis | 7 |
| Idiopathic Pulmonary Fibrosis | 6 |
| Fibrosis | 3 |
| Scleroderma, Systemic | 3 |
| Hypertension, Pulmonary | 2 |
| Idiopathic Interstitial Pneumonias | 2 |
| Lung Diseases | 2 |
| Scleroderma, Diffuse | 2 |
| Alveolitis, Extrinsic Allergic | 1 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.